Study links lower proportions of certain sleep stages to brain changes associated with Alzheimer’s disease

New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer’s disease over time.

Results show that individuals with lower proportions of time spent in slow wave sleep and rapid eye movement sleep had smaller volumes in critical brain regions, particularly the inferior parietal region, which is known to undergo early structural changes in Alzheimer’s disease.

The results were adjusted for potential confounders, including demographic characteristics, smoking history, alcohol use, hypertension, and coronary heart disease.

“Our findings provide preliminary evidence that reduced neuroactivity during sleep may contribute to brain atrophy, thereby potentially increasing the risk of Alzheimer’s disease,” said lead author Gawon Cho, who has a doctorate in public health and is a postdoctoral associate at Yale School of Medicine in New Haven, Connecticut.

“These results are particularly significant because they help characterize how sleep deficiency, a prevalent disturbance among middle-aged and older adults, may relate to Alzheimer’s disease pathogenesis and cognitive impairment.”

The study was published in the Journal of Clinical Sleep Medicine.

According to the Alzheimer’s Association, Alzheimer’s disease is a degenerative brain disease and the most common cause of dementia. An estimated 6.7 million Americans aged 65 and older are living with Alzheimer’s disease, and this number is projected to double by 2060, pending medical developments to prevent, slow or cure the disease.

The study involved an analysis of data from 270 participants who had a median age of 61 years; 53% were female, and all participants were white. Individuals were excluded from the analysis if they previously had a stroke or probable dementia or other significant brain pathology.

The research utilized polysomnography to assess baseline sleep architecture. Advanced brain imaging techniques were used to measure brain volumes 13 to 17 years later.

According to the authors, the study demonstrates an important association between sleep and long-term brain health, and it highlights potential opportunities to reduce the risk of Alzheimer’s disease.

“Sleep architecture may be a modifiable risk factor for Alzheimer’s disease and related dementias, posing the opportunity to explore interventions to reduce risk or delay Alzheimer’s onset,” said Cho.

The researchers emphasized that further investigation is needed to fully understand the causal relationships between sleep architecture and Alzheimer’s disease progression.

New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer’s disease over time.

Results show that individuals with lower proportions of time spent in slow wave sleep and rapid eye movement sleep had smaller volumes in critical brain regions, particularly the inferior parietal region, which is known to undergo early structural changes in Alzheimer’s disease.

The results were adjusted for potential confounders, including demographic characteristics, smoking history, alcohol use, hypertension, and coronary heart disease.

“Our findings provide preliminary evidence that reduced neuroactivity during sleep may contribute to brain atrophy, thereby potentially increasing the risk of Alzheimer’s disease,” said lead author Gawon Cho, who has a doctorate in public health and is a postdoctoral associate at Yale School of Medicine in New Haven, Connecticut.

“These results are particularly significant because they help characterize how sleep deficiency, a prevalent disturbance among middle-aged and older adults, may relate to Alzheimer’s disease pathogenesis and cognitive impairment.”

The study was published in the Journal of Clinical Sleep Medicine.

According to the Alzheimer’s Association, Alzheimer’s disease is a degenerative brain disease and the most common cause of dementia. An estimated 6.7 million Americans aged 65 and older are living with Alzheimer’s disease, and this number is projected to double by 2060, pending medical developments to prevent, slow or cure the disease.

The study involved an analysis of data from 270 participants who had a median age of 61 years; 53% were female, and all participants were white. Individuals were excluded from the analysis if they previously had a stroke or probable dementia or other significant brain pathology.

The research utilized polysomnography to assess baseline sleep architecture. Advanced brain imaging techniques were used to measure brain volumes 13 to 17 years later.

According to the authors, the study demonstrates an important association between sleep and long-term brain health, and it highlights potential opportunities to reduce the risk of Alzheimer’s disease.

“Sleep architecture may be a modifiable risk factor for Alzheimer’s disease and related dementias, posing the opportunity to explore interventions to reduce risk or delay Alzheimer’s onset,” said Cho.

The researchers emphasized that further investigation is needed to fully understand the causal relationships between sleep architecture and Alzheimer’s disease progression.